All Stories

  1. Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC

    Article • September 2020, European Respiratory Society (ERS)

    Michael Loebinger

  2. Efficacy of inhaled dry powder tobramycin (TOBI Podhaler) in P. aeruginosa infected patients with bronchiectasis - iBEST study

    Article • September 2020, European Respiratory Society (ERS)

    Michael Loebinger

  3. Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study

    Article • European Respiratory Journal, August 2020, European Respiratory Society (ERS)

    Michael Loebinger

  4. Patient reported outcomes for non-tuberculous mycobacterial disease

    Article • European Respiratory Journal, January 2020, European Respiratory Society (ERS)

    Michael Loebinger

  5. Non-tuberculous mycobacterial pulmonary disease

    Article • European Respiratory Journal, June 2019, European Respiratory Society (ERS)

    Michael Loebinger

  6. Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection

    Article • American Journal of Respiratory Cell and Molecular Biology, April 2018, American Thoracic Society

    Michael Loebinger

  7. NTM in Bronchiectasis

    Article • December 2017, Springer Science + Business Media

    Michael Loebinger

  8. Mycobacterium avium complex infection: phenotypes and outcomes

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Michael Loebinger

  9. A longitudinal study characterising a large adult primary ciliary dyskinesia population

    Article • European Respiratory Journal, June 2016, European Respiratory Society (ERS)

    Amelia Shoemark, Michael Loebinger

  10. Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles

    Article • International Journal of Nanomedicine, May 2016, Dove Medical Press

    Michael Loebinger

  11. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Michael Loebinger

  12. The reproducibility and responsiveness of the lung clearance index in bronchiectasis

    Article • European Respiratory Journal, September 2015, European Respiratory Society (ERS)

    Michael Loebinger

  13. Screening for latent tuberculosis before tumour necrosis factor antagonist therapy

    Article • European Respiratory Journal, April 2015, European Respiratory Society (ERS)

    Michael Loebinger